Papaverini Hydrochloridum Solutio Darnitsa may be available in the countries listed below.
Papaverine hydrochloride (a derivative of Papaverine) is reported as an ingredient of Papaverini Hydrochloridum Solutio Darnitsa in the following countries:
International Drug Name Search
Theophyllin retard-ratiopharm may be available in the countries listed below.
Theophylline is reported as an ingredient of Theophyllin retard-ratiopharm in the following countries:
International Drug Name Search
Baclofen-Pol may be available in the countries listed below.
Baclofen is reported as an ingredient of Baclofen-Pol in the following countries:
International Drug Name Search
Prazifen may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Fenbendazole is reported as an ingredient of Prazifen in the following countries:
Praziquantel is reported as an ingredient of Prazifen in the following countries:
International Drug Name Search
Drina may be available in the countries listed below.
Cyproterone is reported as an ingredient of Drina in the following countries:
Ethinylestradiol is reported as an ingredient of Drina in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Buspirone (buspirone systemic) is a member of the drug class miscellaneous anxiolytics, sedatives and hypnotics and is used to treat Anxiety, Panic Disorder and Sexual Dysfunction - SSRI Induced.
US matches:
UK matches:
Rec.INN
N05BE01
0036505-84-7
C21-H31-N5-O2
385
Anxiolytic agent
8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| SPC | Summary of Product Characteristics (UK) |
| USAN | United States Adopted Name |
ACTIVE INGREDIENT (IN EACH 10 ml)
SODIUM FLUORIDE 4.4 mg PURPOSE - ANTICAVITY
INACTIVE INGREDIENTS: DEMINERALIZED WATER, MONOSODIUM PHOSPHATE, SODIUM BENZOATE, SODIUM SACCHARIN, ARTIFICIAL COLORING, ARTIFICIAL FLAVORING
AIDS IN THE PREVENTION OF DENTAL DECAY
KEEP OUT OF REACH OF CHILDREN
ADULTS AND CHILDREN 6 YEARS AND OLDER
USE ONCE A DAY AFTER BRUSHING YOUR TEETH WITH TOOTHPASTE. VIGOROUSLY SWISH 10 MILLILITERS (10 ml ON CAP OR 2 TEASPOONS) OF RINSE BETWEEN YOUR TEETH FOR 1 MINUTE THEN SPIT OUT. DO NOT EAT OR DRINK FOR 30 MINUTES AFTER RINSING. INSTRUCT CHILDREN UNDER 12 YEARS OF AGE IN GOOD RINSING HABITS TO AVOID SWALLOWING.
CHILDREN UNDER 6
CONSULT A DENTIST OR PHYSICIAN
STORE AT ROOM TEMPERATURE
QUESTIONS? COMMENTS? CALL 1-479-787-5168 M-F 9 am TO 5pm CST
WHEN USING THIS PRODUCT DO NOT SWALLOW UNLESS TOLD TO DO SO BY A DENTIST OR PHYSICIAN.
IF MORE SOLUTION IS ACCIDENTALLY SWALLOWED THAN USED FOR RINSING, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.
ORTHOGUARD ANTI-CAVITY FLUORIDE RINSE 0.044% SODIUM FLUORIDE IN AN ACIDULATED PHOSPHATE TOPICAL SOLUTION. MANUFACTURED BY MASSCO DENTAL A DIVISION OF DUNAGIN PHARMACEUTICALS, GRAVETTE AR (479) 787-5168. WWW.MASSCODENTAL.NET
| Ortho Guard sodium fluoride gel, dentifrice | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph final | part355 | 01/01/1989 | |
| Ortho Guard sodium fluoride gel, dentifrice | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph final | part355 | 01/01/1989 | |
| Ortho Guard sodium fluoride gel, dentifrice | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph final | part355 | 01/01/1998 | |
| Ortho Guard sodium fluoride gel, dentifrice | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph final | part355 | 01/01/1989 | |
| Labeler - Massco Dental A Division of Dunacin Pharmaceuticals (008081858) |
| Registrant - Massco Dental A Division of Dunacin Pharmaceuticals (008081858) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Massco Dental A Division of Dunacin Pharmaceuticals | 008081858 | manufacture | |
Oprax may be available in the countries listed below.
Omeprazole is reported as an ingredient of Oprax in the following countries:
International Drug Name Search
Kenalgesic may be available in the countries listed below.
Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Kenalgesic in the following countries:
International Drug Name Search
Nycoplus Neo-Fer may be available in the countries listed below.
Ferrous Fumarate is reported as an ingredient of Nycoplus Neo-Fer in the following countries:
International Drug Name Search
Olanzapine pamoate may be available in the countries listed below.
Olanzapine pamoate (USAN) is known as Olanzapine in the US.
International Drug Name Search
Glossary
| USAN | United States Adopted Name |
Poviral may be available in the countries listed below.
Aciclovir is reported as an ingredient of Poviral in the following countries:
International Drug Name Search
